Clinical Trial Update: Observational Study of Raxibacumab in Sporadic Cases of Systemic Anthrax

View source ↗

Summary

This is an observational study evaluating raxibacumab for sporadic systemic anthrax cases, sponsored by Emergent BioSolutions, and not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anthrax

Drugs mentioned

• Raxibacumab (raxibacumab)

Snippet

Sponsor: Emergent BioSolutions | Conditions: Infections, Bacterial | Status: NOT_YET_RECRUITING